Skip to content
, Neurochemistry
Menu
    MENUMENU
    • Home
      • About
      • Cognitive Neuroscience
      • Psychology
      • Lectures
      • Media
      • Statistics
      • Researchers
      • News
      • Contact
    • Psilocybin Facts
      • Ongoing/recently completed clinical trials
      • Psilocybin Patents
        • Top 100 Psilocybin patents
        • ≈1150 Psilocybin related patents
      • Molecular Structure & Chemical Details
      • Structural relatives of psilocybin
      • Psilocybin fungi taxonomies and their endemic habitat
      • The ancient history of psilocybin
    • Neuroscience
      • Neurochemical correlates of creativity
      • The default-mode network (DMN)
      • Psilocybin as a partial agonist of the 5-HT2A receptor
      • Psilocybin and neuroplasticity
      • Cross-modal synesthesia
      • The Adrenochrome Hypothesis of Schizophrenia
      • Psilocybin induced neurogenesis
      • Psilocybin and visual perception
    • Psychology
      • The origin of the term "psychedelic"
      • Psilocybin as a treatment for addiction
      • Psilocybin in the treatment of depressive disorders
      • Psilocybin as a therapeutic adjunct for PTSD
      • Psilocybin as a catalyst of spiritual experiences
      • Psilocybin and ego-dissolution
      • Psilocybin and near-death anxiety
      • Psilocybin and creativity
      • Psilocybin and metacognition
      • Psilocybin and visual perception
      • Psilocybin in a cross-cultural context
      • Psilocybin and shamanism
      • Cross-modal synesthesia
      • Mycelia networks, adaptogens, and mental health
    • Philosophy of Mind
      • The Knowledge Argument: The Ineffability of Qualia
    • Blog
    • Newsletter
    • Search

          • Intelligent AJAX search function

            Generic selectors
            Exact matches only
            Search in title
            Search in content
            Search in posts
            Search in pages

          • Site structure

            SiteMap Tree Interactive Mind Map

Neurochemistry

, Neurochemistry
, Neurochemistry

Machine Learning Powered AI Translation

, Neurochemistry English
, Neurochemistry Afrikaans, Neurochemistry العربية, Neurochemistry বাংলা, Neurochemistry Български, Neurochemistry 简体中文, Neurochemistry Hrvatski, Neurochemistry Čeština‎, Neurochemistry Dansk, Neurochemistry Nederlands, Neurochemistry English, Neurochemistry Filipino, Neurochemistry Suomi, Neurochemistry Français, Neurochemistry Deutsch, Neurochemistry Ελληνικά, Neurochemistry ગુજરાતી, Neurochemistry עִבְרִית, Neurochemistry हिन्दी, Neurochemistry Italiano, Neurochemistry 日本語, Neurochemistry 한국어, Neurochemistry Latviešu valoda, Neurochemistry മലയാളം, Neurochemistry नेपाली, Neurochemistry Norsk bokmål, Neurochemistry فارسی, Neurochemistry Polski, Neurochemistry Português, Neurochemistry Русский, Neurochemistry Slovenščina, Neurochemistry Español, Neurochemistry Svenska, Neurochemistry தமிழ், Neurochemistry ไทย, Neurochemistry Türkçe, Neurochemistry اردو, Neurochemistry Zulu

Search Function

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Anything in here will be replaced on browsers that support the canvas element
  • Ego-dissolution
  • Creativity
  • Ego-death
  • Psilocybin Patents
  • Psilocybin Innovations
  • Schizophrenia
  • Shamanism
  • Albert Hofmann
  • Psilocybin
  • Hippocampus
  • 5-HT2A receptor
  • Neuroplasticity
  • Neurogenesis
  • Epidemiology
  • Suicidality
  • Mental Health
  • Openness to Experience
  • 5-Factor Model
  • Personality
  • Clinical Trials
  • Experimental Studies
  • Controlled Scientific Research

Recent Posts

  • Karry B. Mullis “Getting down with the molecules”
  • Psilocybin & Mental Health

Categories

Search Function

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Tags

5-Factor Model5-HT2A receptorAlbert HofmannClinical TrialsCreativityEgo-deathEgo-dissolutionEpidemiologyHippocampusMental HealthNeurogenesisNeuroplasticityOpenness to ExperiencePersonalityPsilocybinPsilocybin InnovationsPsilocybin PatentsSchizophreniaShamanismSuicidality

Categories

  • Annecdotal evidence
  • Empirical studies
  • Media reports
  • Misc

Translation

, Neurochemistry English
, Neurochemistry Afrikaans, Neurochemistry العربية, Neurochemistry বাংলা, Neurochemistry Български, Neurochemistry 简体中文, Neurochemistry Hrvatski, Neurochemistry Čeština‎, Neurochemistry Dansk, Neurochemistry Nederlands, Neurochemistry English, Neurochemistry Filipino, Neurochemistry Suomi, Neurochemistry Français, Neurochemistry Deutsch, Neurochemistry Ελληνικά, Neurochemistry ગુજરાતી, Neurochemistry עִבְרִית, Neurochemistry हिन्दी, Neurochemistry Italiano, Neurochemistry 日本語, Neurochemistry 한국어, Neurochemistry Latviešu valoda, Neurochemistry മലയാളം, Neurochemistry नेपाली, Neurochemistry Norsk bokmål, Neurochemistry فارسی, Neurochemistry Polski, Neurochemistry Português, Neurochemistry Русский, Neurochemistry Slovenščina, Neurochemistry Español, Neurochemistry Svenska, Neurochemistry தமிழ், Neurochemistry ไทย, Neurochemistry Türkçe, Neurochemistry اردو, Neurochemistry Zulu

Psilocybin Newsletter

Quotation

When we look within ourselves with psilocybin, we discover that we do not have to look outward toward the futile promise of life that circles distant stars in order to still our cosmic loneliness. We should look within; the paths of the heart lead to nearby universes full of life and affection for humanity.Terrence McKenna (*1946;†2000)
, Neurochemistry
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
(CC) 2016— by Dr. Christopher B. Germann (PhD, MSc, BSc, Marie Curie Alumnus)
https://neuropsy-webdesign.de
The project www.Psilocybin-Research.com was funded by the EU Marie Curie Initial Training Network FP7-PEOPLE-2013-ITN-604764
→ Primary goals of research and innovation policy as defined by the European Comission: Open Innovation, Open Science, Open to the World.
, Neurochemistry

Legal disclaimer: The interdisciplinary Marie Curie CogNovo program has been intentionally designed by the European Union and the University of Plymouth (United Kingdom) to discuss and disseminate a wide view on a diverse spectrum of topics including psychology, neuroscience, current affairs, basic science, humanities, and the arts, inter alia. Note that the views and opinions expressed on this website do not necessarily represent the opinions of any of the institutions mentioned on this website and belong exclusively to the copyright holder. The CogNovo program explicitly emphasises cognitive and social innovation, the generation of new ideas and perspectives, and the probing of boundaries, but see https://www.cognovo.eu/about/
Copyright © 2021 Psilocybin Research – OnePress theme by FameThemes